Cargando…
Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins
Bacteriocins produced by lactic acid bacteria (LAB-bacteriocins) may serve as alternatives for aging antibiotics. LAB-bacteriocins can be used alone, or in some cases as potentiating agents to treat bacterial infections. This approach could meet the different calls and politics, which aim to reduce...
Autores principales: | Pérez-Ramos, Adrián, Madi-Moussa, Désiré, Coucheney, Françoise, Drider, Djamel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538875/ https://www.ncbi.nlm.nih.gov/pubmed/34683428 http://dx.doi.org/10.3390/microorganisms9102107 |
Ejemplares similares
-
Expression of five class II bacteriocins with activity against Escherichia coli in Lacticaseibacillus paracasei CNCM I-5369, and in a heterologous host
por: Madi-Moussa, Désiré, et al.
Publicado: (2021) -
Lacticaseicin 30 and Colistin as a Promising Antibiotic Formulation against Gram-Negative β-Lactamase-Producing Strains and Colistin-Resistant Strains
por: Madi-Moussa, Désiré, et al.
Publicado: (2021) -
Structure of Lacticaseicin 30 and Its Engineered Variants Revealed an Interplay between the N-Terminal and C-Terminal Regions in the Activity against Gram-Negative Bacteria
por: Madi-Moussa, Désiré, et al.
Publicado: (2022) -
Evidence for the Involvement of Pleckstrin Homology Domain-Containing Proteins in the Transport of Enterocin DD14 (EntDD14); a Leaderless Two-Peptide Bacteriocin
por: Pérez-Ramos, Adrián, et al.
Publicado: (2021) -
Anti-adhesion and Anti-inflammatory Potential of the Leaderless Class IIb Bacteriocin Enterocin DD14
por: Teiar, Radja, et al.
Publicado: (2022)